NYMC Faculty Publications
Corrigendum: Myelomodulatory Treatments Augment the Therapeutic Benefit of Oncolytic Viroimmunotherapy in Murine Models of Malignant Peripheral Nerve Sheath Tumors
Author Type(s)
Faculty
DOI
10.3389/fimmu.2024.1456897
Journal Title
Frontiers in Immunology
First Page
1456897
Document Type
Article
Publication Date
1-1-2024
Department
Pediatrics
Abstract
[This corrects the article DOI: 10.3389/fimmu.2024.1384623.].
Recommended Citation
Paudel, S. N., Hutzen, B. J., Miller, K. E., Garfinkle, E. A., Chen, C., Wang, P., Glaspell, A. M., Currier, M. A., Ringwalt, E. M., Boon, L., Mardis, E. R., Cairo, M. S., Ratner, N., Dodd, R. D., Cassady, K. A., & Cripe, T. P. (2024). Corrigendum: Myelomodulatory Treatments Augment the Therapeutic Benefit of Oncolytic Viroimmunotherapy in Murine Models of Malignant Peripheral Nerve Sheath Tumors. Frontiers in Immunology, 15, 1456897. https://doi.org/10.3389/fimmu.2024.1456897